Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients.

Troya J, Cuevas G, Ryan P, Díez V, Izquierdo E, Escobar I, Solís J.

Open Forum Infect Dis. 2017 Aug 7;4(3):ofx164. doi: 10.1093/ofid/ofx164. eCollection 2017 Summer.

2.

Confusion in the Study of Immune Reconstitution Inflammatory Syndrome.

Alvarado-de la Barrera C, Reyes-Terán G.

Pathog Immun. 2017;2(1):126-137. doi: 10.20411/pai.v2i1.195. Epub 2017 May 2.

3.

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review.

Kroesen VM, Gröschel MI, Martinson N, Zumla A, Maeurer M, van der Werf TS, Vilaplana C.

Front Immunol. 2017 Jun 30;8:772. doi: 10.3389/fimmu.2017.00772. eCollection 2017. Review.

4.

Prolonged paradoxical reaction to anti-tuberculous treatment after discontinuation of TNF-alpha- blocker therapy with adalimumab. Rare clinical documentation.

Falkenstern-Ge RF, Husemann K, Kohlhäufl M.

Open Med (Wars). 2014 Oct 8;10(1):39-43. doi: 10.1515/med-2015-0009. eCollection 2015.

5.

TB-IRIS: Proteomic analysis of in vitro PBMC responses to Mycobacterium tuberculosis and response modulation by dexamethasone.

Bell L, Peyper JM, Garnett S, Tadokera R, Wilkinson R, Meintjes G, Blackburn JM.

Exp Mol Pathol. 2017 Apr;102(2):237-246. doi: 10.1016/j.yexmp.2017.02.008. Epub 2017 Feb 14.

6.

Immune reconstitution inflammatory syndrome associated with pulmonary pathogens.

Gopal R, Rapaka RR, Kolls JK.

Eur Respir Rev. 2017 Jan 3;26(143). pii: 160042. doi: 10.1183/16000617.0042-2016. Print 2017 Jan. Review.

7.

Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis.

Marais S, Lai RPJ, Wilkinson KA, Meintjes G, O'Garra A, Wilkinson RJ.

J Infect Dis. 2017 Mar 1;215(5):677-686. doi: 10.1093/infdis/jiw561.

8.

Immune reconstitution inflammatory syndrome in HIV infection: taking the bad with the good.

Wong CS, Richards ES, Pei L, Sereti I.

Oral Dis. 2017 Oct;23(7):822-827. doi: 10.1111/odi.12606. Epub 2016 Dec 23.

PMID:
27801977
9.

Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis.

Gopalan N, Chandrasekaran P, Swaminathan S, Tripathy S.

AIDS Res Ther. 2016 Sep 26;13:34. eCollection 2016. Review.

10.

Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors.

Bana TM, Lesosky M, Pepper DJ, van der Plas H, Schutz C, Goliath R, Morroni C, Mendelson M, Maartens G, Wilkinson RJ, Meintjes G.

BMC Infect Dis. 2016 Sep 27;16(1):518.

11.

Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV.

Narendran G, Kavitha D, Karunaianantham R, Gil-Santana L, Almeida-Junior JL, Reddy SD, Kumar MM, Hemalatha H, Jayanthi NN, Ravichandran N, Krishnaraja R, Prabhakar A, Manoharan T, Nithyananthan L, Arjunan G, Natrajan M, Swaminathan S, Andrade BB.

PLoS One. 2016 Sep 19;11(9):e0163298. doi: 10.1371/journal.pone.0163298. eCollection 2016.

12.

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial).

Stek C, Schutz C, Blumenthal L, Thienemann F, Buyze J, Nöstlinger C, Ravinetto R, Wouters E, Colebunders R, Maartens G, Wilkinson RJ, Lynen L, Meintjes G.

JMIR Res Protoc. 2016 Aug 29;5(3):e173. doi: 10.2196/resprot.6046.

13.

Integrated therapy for HIV and tuberculosis.

Manosuthi W, Wiboonchutikul S, Sungkanuparph S.

AIDS Res Ther. 2016 May 12;13:22. doi: 10.1186/s12981-016-0106-y. eCollection 2016. Review.

14.

Acute respiratory distress syndrome caused by Mycoplasma pneumoniae without elevated pulmonary vascular permeability: a case report.

Takahashi N, Shinohara T, Oi R, Ota M, Toriumi S, Ogushi F.

J Thorac Dis. 2016 May;8(5):E319-24. doi: 10.21037/jtd.2016.03.08.

15.

In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.

Bell LC, Pollara G, Pascoe M, Tomlinson GS, Lehloenya RJ, Roe J, Meldau R, Miller RF, Ramsay A, Chain BM, Dheda K, Noursadeghi M.

PLoS Pathog. 2016 Mar 17;12(3):e1005469. doi: 10.1371/journal.ppat.1005469. eCollection 2016 Mar.

16.

Biomarkers for Identifying Risk of Immune Reconstitution Inflammatory Syndrome.

Wilkinson KA, Walker N.

EBioMedicine. 2016 Feb 6;4:9-10. doi: 10.1016/j.ebiom.2016.02.013. eCollection 2016 Feb. No abstract available.

17.

Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections.

Panackal AA, Williamson KC, van de Beek D, Boulware DR, Williamson PR.

MBio. 2016 Jan 26;7(1):e01906-15. doi: 10.1128/mBio.01906-15. Review.

18.

Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda.

Rhein J, Bahr NC, Hemmert AC, Cloud JL, Bellamkonda S, Oswald C, Lo E, Nabeta H, Kiggundu R, Akampurira A, Musubire A, Williams DA, Meya DB, Boulware DR; ASTRO-CM Team.

Diagn Microbiol Infect Dis. 2016 Mar;84(3):268-73. doi: 10.1016/j.diagmicrobio.2015.11.017. Epub 2015 Dec 1.

19.

HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.

Lai RP, Meintjes G, Wilkinson RJ.

Semin Immunopathol. 2016 Mar;38(2):185-98. doi: 10.1007/s00281-015-0532-2. Epub 2015 Sep 30. Review.

20.

HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling.

Lai RP, Meintjes G, Wilkinson KA, Graham CM, Marais S, Van der Plas H, Deffur A, Schutz C, Bloom C, Munagala I, Anguiano E, Goliath R, Maartens G, Banchereau J, Chaussabel D, O'Garra A, Wilkinson RJ.

Nat Commun. 2015 Sep 24;6:8451. doi: 10.1038/ncomms9451.

Supplemental Content

Support Center